![Pharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer]()
Pharmacokinetic and exposure–response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancerQuartino, Angelica L.; Li, Hanbin; Jin, Jin Y.; Wada, D. Russell; Benyunes, Mark C.; McNally, Virginia; Viganò, Lucia; Nijem, Ihsan; Lum, Bert L.; Garg, Amit · Cancer Chemotherapy and Pharmacology · 2017